The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
INFLUENTIAL PUBLICATIONFull Access

Bibliography for Child and Adolescent Psychiatry

Published Online:https://doi.org/10.1176/foc.2.4.550

This section contains a compilation of recent publications that have shaped the thinking in the field as well as classic works that remain important to the subject reviewed in this issue. This bibliography has been compiled by experts in the field and members of the editorial and advisory boards. Entries are listed chronologically within sections. Articles from the bibliography that are reprinted in this issue are in bold type.

Attention deficit hyperactivity disorder

Biederman J, Spencer T, Wilens T: Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder. Int J Neuropsychopharmacol 2004; 7:77–97

MTA Cooperative Group: National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder. Pediatrics 2004; 113:754–761

MTA Cooperative Group: National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment. Pediatrics 2004; 113:762–769

Greenhill LL, Pliszka S, Dulcan MK, Bernet W, Arnold V, Beitchman J, Benson RS, Bukstein O, Kinlan J, McClellan J, Rue D, Shaw JA, Stock S; American Academy of Child and Adolescent Psychiatry: Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry 2002; 41(2 suppl): 26S–49S

Swanson JM, Sergeant JA, Taylor E, Sonuga-Barke EJ, Jensen PS, Cantwell DP: Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet 1998; 351(9100):429–433

Biederman J, Wilens T, Mick E, Faraone SV, Weber W, Curtis S, Thornell A, Pfister K, Jetton JG, Soriano J: Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 1997; 36:21–29

Biederman J, Faraone S, Milberger S, Guite J, Mick E, Chen L, Mennin D, Marrs A, Ouellette C, Moore P, Spencer T, Norman D, Wilens T, Kraus I, Perrin J: A prospective 4-year follow-up study of attention-deficit hyperactivity and related disorders. Arch Gen Psychiatry 1996; 53:437–446

Cantwell DP: Attention deficit disorder: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 1996; 35:978–987

Castellanos FX, Giedd JN, Marsh WL, Hamburger SD, Vaituzis AC, Dickstein DP, Sarfatti SE, Vauss YC, Snell JW, Lange N, Kaysen D, Krain AL, Ritchie GF, Rajapakse JC, Rapoport JL: Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder. Arch Gen Psychiatry 1996; 53:607–616

Spencer T, Biederman J, Wilens T, Harding M, O’Donnell BAD, Griffin S: Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry 1996; 35:409–432

Bipolar disorder

Pavuluri MN, Henry DB, Devineni B, Carbray JA, Naylor MW, Janicak PG: A pharmacotherapy algorithm for stabilization and maintenance of pediatric bipolar disorder. J Am Acad Child Adolesc Psychiatry 2004; 43:859–867

Wolf DV, Wagner KD: Bipolar disorder in children and adolescents. CNS Spectrums 2003; 8:954–959

Geller B, Luby J: Child and adolescent bipolar disorder: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 1997; 36:1168–1176

Obsessive-compulsive disorder

Franklin M, Foa E, March JS: The pediatric obsessive-compulsive disorder treatment study: rationale, design, and methods. J Child Adolesc Psychopharm 2003; 13(suppl 1):S39–S51

Riddle MA, Reeve EA, Yaryura-Tobias JA, Yang HM, Claghorn JL, Gaffney G, Greist JH, Holland D, McConville BJ, Pigott T, Walkup JT: Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial. J Am Acad Child Adolesc Psychiatry 2001; 40:222–229

Depression

Emslie GJ, Hughes CW, Crismon ML, Lopez M, Pliszka S, Toprac MG, Boemer C; Texas Children’s Medication Algorithm Project (CMAP): A feasibility study of the childhood depression medication algorithm: the Texas Children’s Medication Algorithm Project (CMAP). J Am Acad Child Adolesc Psychiatry 2004; 43:519–527

Emslie GJ, Heiligenstein JH, Wagner KD, Hoog SL, Ernest DE, Brown E, Nilsson M, Jacobson JG: Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial. J Am Acad Child Adolesc Psychiatry 2002; 41:1205–1215

Beardslee WR, Gladstone TR: Prevention of childhood depression: recent findings and future prospects. Biol Psychiatry 2001; 49:1101–1110

Birmaher B, Ryan ND, Williamson DE, Brent DA, Kaufman J, Dahl RE, Perel J, Nelson B: Childhood and adolescent depression: a review of the past 10 years (part I). J Am Acad Child Adolesc Psychiatry 1996; 35:1427–1439

Suicide

Treatment for Adolescents With Depression Study: Short-term effectiveness and safety outcomes. JAMA, in press

Mann JJ: Neurobiology of suicidal behaviour. Nat Rev Neurosci 2003; 4:819–828

Olfson M, Shaffer D, Marcus SC, Greenberg T: Relationship between antidepressant medication treatment and suicide in adolescents. Arch Gen Psychiatry 2003; 60:978–982

Velting DM, Gould MS: Suicide contagion, in Review of Suicidology 1997. Edited by Maris R, Canetto S, Silverman MM. New York, Guilford, 1997, pp 96–136

American Academy of Child and Adolescent Psychiatry: Practice Parameter for the Assessment and Treatment of Children and Adolescents with Suicidal Behavior. J Am Acad Child Adolesc Psychiatry 2001; 40(7 suppl): 24S–51S

Lewinsohn PM, Rohde P, Seeley JR: Adolescent suicidal ideation and attempts: prevalence, risk factors, and clinical implications. Clinical Psychology: Science and Practice 1996; 3:25–46

Shaffer D, Gould MS, Fisher P, Trautman P, Moreau D, Kleinman M, Flory M: Psychiatric diagnosis in child and adolescent suicide. Arch Gen Psychiatry 1996; 53:339–348

Autism

Volkmar FR, Lord C, Bailey A, Schultz RT, Klin A: Autism and pervasive developmental disorders. J Child Psychol Psychiatry 2004; 45:135–170

Manning-Courtney P, Brown J, Molloy CA, Reinhold J, Murray D, Sorensen-Burnworth R, Messerschmidt T, Kent B: Diagnosis and treatment of autism spectrum disorders. Curr Probl Pediatr Adolesc Health Care 2003; 33:283–304

Klin A, Jones W, Schultz R, Volkmar F, Cohen D: Defining and quantifying the social phenotype in autism. Am J Psychiatry 2002; 159:895–908

Bailey A, Lecouteur A, Gottesman I, Bolton P, Simonoff E, Yuzda E, Rutter M: Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med 1995; 25:63–77

General

FDA Talk Paper: FDA issues public health advisory on cautions for use of antidepressants in adults and children. March 22, 2004. Available at www.fda.gov/bbs/topics/ANSWERS/2004/ANS01283.html

Fremont WP: Childhood reactions to terrorism-induced trauma: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 2004; 43:381–392

Zametkin AJ, Zoon CK, Klein HW, Munson S: Psychiatric aspects of child and adolescent obesity: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 2004; 43:134–150

Collett BR, Ohan JL, Myers KM: Ten-year review of rating scales, VI: scales assessing externalizing behaviors. J Am Acad Child Adolesc Psychiatry 2003; 42:1143–1170

McClellan JM, Werry JS: Evidence-based treatments in child and adolescent psychiatry: an inventory. J Am Acad Child Adolesc Psychiatry 2003; 42:1388–1400

Schur SB, Sikich L, Findling RL, Malone RP, Crismon ML, Derivan A, MacIntyre JC II, Pappadopulos E, Greenhill L, Schooler N, Van Orden K, Jensen PS: Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY), part I: a review. J Am Acad Child Adolesc Psychiatry 2003; 42:132–144

Pappadopulos E, MacIntyre JC II, Crismon ML, Findling RL, Malone RP, Derivan A, Schooler N, Sikich L, Greenhill L, Schur SB, Felton CJ, Kranzler H, Rube DM, Sverd J, Finnerty M, Ketner S, Siennick SE, Jensen PS: Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY), part II. J Am Acad Child Adolesc Psychiatry 2003; 42:145–161

Terr LC: “Wild Child”: how three principles of healing organized 12 years of psychotherapy. J Am Acad Child Adolesc Psychiatry 2003; 42:1401–1409

Varley CK, Smith CJ: Anxiety disorders in the child and teen. Pediatr Clin North Am 2003; 50:1107–1138

Vaughan BL, Levy S, Knight JR: Adolescent substance use: prevention and management by primary care clinicians. J Clin Outcomes Manage 2003; 10:167–175

Wasserman GA, Jensen PS, Ko SJ, Cocozza J, Trupin E, Angold A, Cauffman E, Grisso T: Mental health assessments in juvenile justice: report on the consensus conference. J Am Acad Child Adolesc Psychiatry 2003; 42:752–761

Zito JM, Safer DJ, DosReis S, Gardner JF, Magder L, Soeken K, Boles M, Lynch F, Riddle MA: Psychotropic practice patterns for youth: a 10-year perspective. Arch Pediatr Adolesc Med 2003; 157:17–25

Aman MG, De Smedt G, Derivan A, Lyons B, Findling RL; Risperidone Disruptive Behavior Study Group: Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence. Am J Psychiatry 2002; 159:1337–1346

Burke JD, Loeber R, Birmaher B: Oppositional defiant disorder and conduct disorder: a review of the past 10 years, part II: J Am Acad Child Adolesc Psychiatry 2002; 41:1275–1293

Geller B, Zimerman B, Williams M, Delbello MP, Bolhofner K, Craney JL, Frazier J, Beringer L, Nickelsburg MJ: DSM-IV mania symptoms in a prepubertal and early adolescent bipolar disorder phenotype compared to attention-deficit hyperactive and normal controls. J Child Adolesc Psychopharm 2002; 12:11–25

Pine DS: Treating children and adolescents with selective serotonin reuptake inhibitors: how long is appropriate? J Child Adolesc Psychopharmacol 2002; 12:189–203

Solantaus-Simula T, Punamaki RL, Beardslee WR: Children’s responses to low parental mood, II: associations with family perceptions of parenting styles and child distress. J Am Acad Child Adolesc Psychiatry 2002; 41: 287–295

DeMaso DR: Collaboration essentials for child and adolescent psychiatry and pediatric residents: working together to treat the child. DevelopMentor 2001; 8:4. Available at www.aacap.org/training/DevelopMentor/Content/2001Spring/s2001_a1.cfm

VanHorn M, DeMaso DR, Gonzalez-Heydrich J, Dahlmeier EJ: Illness-related concerns of mothers with congenital heart disease. J Am Acad Child Adolescent Psychiatry 2001; 40:847–854

Fairburn CG, Cooper Z, Doll HA, Norman P, O’Connor M: The natural course of bulimia nervosa and binge eating disorder in young women. Arch Gen Psychiatry 2000; 57:659–665

Strober M, Freeman R, Lampert C, Diamond J, Kaye W: Controlled family study of anorexia nervosa and bulimia nervosa: evidence of shared liability and transmission of partial syndromes. Am J Psychiatry 2000;157:393–401

Eaves LJ, Silberg JL, Meyer JM, Maes HH, Simonoff E, Pickles A, Rutter M, Neale MC, Reynolds CA, Erikson MT, Heath AC, Loeber R, Truett KR, Hewitt JK: Genetics and developmental psychopathology, II: the main effects of genes and environment on behavioral problems in the Virginia twin study of adolescent behavioral development. J Child Psychol Psychiat 1997; 38:965–980

Strober M, Freeman R, Morrell W: The long-term course of severe anorexia nervosa in adolescents: survival analysis of recovery, relapse, and outcome predictors over 10–15 years in a prospective study. Int J Eat Disord 1997; 22:339–360